Clinical features and management of vestibulitis
vestibulitis vulvar vestibule treatment
nasal vestibulitis clinical features management 2024
nasal vestibulitis infection folliculitis furuncle nose
Clinical photography of a single nasal skin lesion showing an acute furuncle (boil) on the nasal vestibule/dorsum. The image depicts a solitary, erythematous, dome-shaped nodule with a shiny surface and surrounding mild edema. A palpable tenderness is suggested by the lesion’s conspicuous inflamed halo. A central pustule or crust may be present at the core, consistent with progression toward abscess formation within a pilosebaceous follicle. The lesion is located on the external nasal skin near the nostril, with frontal/anterior perspective offering clear visualization of the nasal bridge region. The clinical diagnosis is furunculosis of the nose, most often caused by Staphylococcus aureus; in this case PVL (Panton-Valentine leukocidin)–producing strains are implicated, which are associated with more aggressive skin and soft tissue infections and a higher risk of complications. Imaging is not radiologic; this is a dermatologic/clinical photograph used for documentation, teaching, and correlating with microbiology culture results. Management implications include incision and drainage if fluctuant, culture to guide antibiotics, and consideration of toxin-producing strains. The image serves educational purposes for dermatology, infectious disease, microbiology, and medical training in recognizing PVL-associated nasal furunculosis and differentiating it from impetigo, cellulitis, and Sty.
This is a clinical dermatology photograph of the nasal region illustrating Trichostasis spinulosa. Modality and technique: digital clinical photography, close-up macro view under standard white-light illumination. The image shows the nose with numerous tiny follicular papules; many dilated follicular openings contain bundles of fine vellus hairs that emerge from a single pore, producing characteristic hair tufts. Surrounding skin may show mild erythema or scale, but there is no overt inflammation. The distribution is localized to the nasal skin (dorsum and tip) and reflects a benign follicular disorder where multiple hair shafts are retained within a single follicle. Diagnostic significance lies in distinguishing TPS from acneiform lesions and folliculitis, guiding appropriate management rather than antimicrobial therapy. Clinically relevant use cases include dermatology education, image-based case discussions, and database curation for machine learning models aimed at recognizing hair-containing follicular disorders. This image captures the hallmark feature of TPS: multiple hair shafts within one follicular opening on nasal skin, contributing to its cosmetic appearance and patient counseling considerations.
This clinical photograph shows a close-up view of the human nose exhibiting signs of vascular compromise and secondary infection following a dermatological procedure. The primary pathology is localized to the nasal tip and dorsum, where a cluster of small, raised, erythematous pustules is prominently visible. These lesions are characterized by a rounded morphology and a deep red to violaceous hue, suggesting intense underlying inflammation and possible infection. The skin of the nasal bridge appears edematous and displays a shiny texture with diffuse erythema extending towards the glabella. In contrast, the skin on the adjacent cheeks maintains a more normal tone and texture, highlighting the localized nature of the inflammatory process. The visual findings are consistent with an infection state and impending tissue necrosis, likely resulting from vascular occlusion post-filler injection. This image serves as a clinical reference for identifying early progression from ischemic stages to pustule formation and potential eschar development in aesthetic medicine complications.
High-resolution clinical photograph of the left nasal ala and midface showing multiple skin-colored to slightly erythematous follicular papules with conspicuous comedo-like plugs along the nasal dorsum and alar rims. The image demonstrates numerous small keratotic plugs within dilated hair follicles, producing a pattern reminiscent of open comedones but clustered centrally on the nose. The underlying process is trichostasis spinulosa, a folliculocentric condition in which several vellus hairs are retained within a single follicular unit and obstructed by keratinous material. Lesion distribution is centrofacial, with highest density on the nose and mild textural coarsening of adjacent skin. The epidermis shows mild hyperkeratosis without overt pustulation or crusting; pigmentation is variable in some areas. Differential diagnoses include acne vulgaris with comedones, keratosis pilaris rubra faceii, and superficial folliculitis. Clinically, recognizing trichostasis spinulosa is important to avoid mislabeling as acne and to guide management toward follicular clearance. Treatment considerations include topical keratolytics (retinoids such as adapalene or tretinoin, benzoyl peroxide), gentle extraction, and adjunctive exfoliation; persistent cases may benefit from laser hair removal or chemical depilation. Image enhances educational awareness of centrofacial follicular occlusion disorders. This image provides a reference for clinicians diagnosing follicular occlusion disorders and tailoring patient education.
nasal vestibulitis treatment antibiotics
PMID: 36373460
For ent subject of mmbs
Nasal Vestibulitis - ENT (MBBS)
Definition
Anatomy Reminder
Etiology / Causative Organism
- Primary organism: Staphylococcus aureus (most common, both MSSA and MRSA)
- Less common: Streptococcal species, fungal infections
- Herpetic (HSV) infections - typically more severe and acute rather than chronic
Risk Factors (Common Exam Point)
| Category | Examples |
|---|---|
| Local trauma | Nose picking, nasal hair plucking, excessive nose blowing |
| Iatrogenic | Nasal steroid sprays (though no confirmed association), nasal surgeries, cauterization |
| Chemotherapy | Taxanes (paclitaxel, nab-paclitaxel), bevacizumab - >75% develop nasal symptoms |
| Systemic | Diabetes mellitus, immunosuppression, obesity |
| Miscellaneous | Nasal piercing, nasal foreign body, poor hygiene |
Clinical Features
Symptoms
- Anterior nasal pain (often the presenting complaint)
- Swelling and tenderness at the nasal tip / ala
- Nasal crusting
- Bleeding (epistaxis - minor)
- Pustule formation just inside the nostril
- Chronic irritation with recurrent symptoms in some patients
Signs on Examination
- Erythema, cracking, and yellow crusting just inside the nostril
- Mild erythema of the vestibular skin
- Tenderness to palpation or movement of the nose
- Nasal septum is typically spared (disease limited to vestibular skin/hair follicles)
- May appear fairly normal in low-grade chronic cases
Spectrum of Disease (Important Classification)
1. Simple Vestibulitis (Folliculitis)
- Superficial infection of hair follicles
- Mild erythema, crusting, tenderness
- Localized to vestibule
2. Furunculosis (Furuncle / Boil)
- Deep variety of vestibulitis
- Perifollicular erythema + edema
- Possible abscess formation (pustule with fluctuation)
- More severe pain and swelling
3. Carbuncle
- A group/cluster of furuncles coalescing together
- More extensive and severe
Non-infective Vestibulitis
- Caused by physical/chemical irritation
- No pus or organisms
- Dryness, cracking, crusting without frank infection
Complications (High-Yield for Exams)
Nasal Vestibulitis
↓
Untreated / Severe
↓
Facial Cellulitis
↓
Cavernous Sinus Thrombosis ← MOST DANGEROUS
↓
Meningitis / Brain Abscess
- Nasal tip cellulitis
- Periorbital cellulitis
- Septicemia (in immunocompromised)
Diagnosis
- Clinical diagnosis - based on history and examination
- No special tests usually needed
- Nasal swab culture - indicated when:
- Symptoms recur or persist
- MRSA suspected
- Systemic involvement
- Immunocompromised patient
- Cultures from abscess yield positive results in ~83% of cases (predominantly MSSA)
Management
A. Non-infective Vestibulitis
- Vaseline (petroleum jelly) applied to vestibule - moisturizes and protects
- Mild topical corticosteroid to reduce inflammation
- Avoid precipitating factors (nose picking, excessive blowing)
B. Infective Vestibulitis - Mild/Moderate (Outpatient)
| Agent | Notes |
|---|---|
| Mupirocin (Bactroban nasal) | Drug of choice; also used for MRSA decolonization |
| Chlorhexidine + Neomycin (Naseptin) | First-line combination; contraindicated in peanut allergy (contains arachis oil); contraindicated in pregnancy |
| Bacitracin, Polymyxin | Alternative topical agents |
| Retapamulin | Alternative topical |
- Applied 3 times a day for 5 days
- Warm compresses help reduce inflammation
- Amoxicillin-clavulanate - most commonly used
- Clindamycin - for penicillin allergy or as second-line
- Anti-staphylococcal agents (flucloxacillin, dicloxacillin)
C. Severe / Complicated Cases (Inpatient)
- Treatment failure in outpatient setting
- Presence of cellulitis or abscess
- Immunocompromised patient
- Signs of spreading infection
- IV antibiotics (IV amoxicillin-clavulanate is most common)
- Incision and drainage (I&D) - for fluctuant abscess
- Add antiviral (valacyclovir) if herpetic infection suspected
D. MRSA Eradication Protocol
- Mupirocin is the second-line agent for MRSA
- Applied 3 times daily for 5 days
- A swab is taken 2 days after completion to confirm MRSA eradication
E. Chemotherapy-associated Nasal Vestibulitis
- Saline nasal sprays - basic supportive care
- Rose geranium in sesame oil nasal spray - evidence supports superiority over saline
Clinical Image
High-Yield Summary Table for MBBS Exams
| Feature | Detail |
|---|---|
| Organism | S. aureus (MSSA > MRSA) |
| Risk factors | Nose picking, hair plucking, DM, immunosuppression |
| Classic symptom | Anterior nasal pain + crusting + tenderness |
| Septum involvement | Usually spared |
| Deep form | Furunculosis (abscess) |
| Multiple furuncles | Carbuncle |
| Dangerous complication | Cavernous sinus thrombosis |
| First-line topical Rx | Mupirocin OR Naseptin |
| MRSA treatment | Mupirocin |
| Naseptin contraindication | Peanut allergy, pregnancy |
| Oral antibiotic | Amoxicillin-clavulanate |
| I&D indication | Fluctuant abscess |
Sources
- K.J. Lee's Essential Otolaryngology - Nasal Vestibulitis section
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol. 1 - Vestibulitis section
- Harrison's Principles of Internal Medicine 22E (2025) - Nasal Vestibulitis
- Textbook of Family Medicine 9e - Nasal Vestibulitis
- Marra P et al. Nasal Vestibulitis and Vestibular Furunculosis: a systematic review. Clin Ter. 2022 (PMID: 36373460)
Clinical features and management of chronic rhinosinusitis for ent subject with deep from standard textbooks
"chronic rhinosinusitis" diagnosis management guidelines
chronic rhinosinusitis nasal polyps endoscopy CT scan sinusitis
This composite clinical image presents a side-by-side comparison of diagnostic modalities for chronic rhinosinusitis (CRS). On the left, a coronal CT scan of the paranasal sinuses shows significant soft tissue opacification in the bilateral maxillary and ethmoid sinuses, indicating a positive diagnosis for sinusitis according to Lund-Mackay staging criteria. The nasal septum is centered, and inferior turbinates are visible. On the right, a corresponding nasofibroscopy (endoscopy) frame provides a direct view of the nasal passage and mucosa. In this specific case, the endoscopic view appears negative for classic signs of CRS, demonstrating smooth mucosa without evident purulent secretion, polyps, or significant edema in the visible meatus. The pairing illustrates a clinical 'disagreement' where radiologic evidence suggests disease that is not immediately visible via endoscopy, highlighting the diagnostic complexity of sinonasal pathology in otolaryngology.
This composite figure displays diagnostic findings of chronic rhinosinusitis with nasal polyps (CRSwNP). Image A is a nasal endoscopy showing a large, pale-pink, fleshy nasal polyp occupying the middle meatus and partially obstructing the nasal passage. Key landmarks include the nasal septum (NS) on the medial side and the inferior nasal turbinate (INT) at the inferior aspect. Image B is a coronal non-contrast CT scan of the paranasal sinuses. It reveals partial opacification and mucosal thickening within the bilateral maxillary, ethmoid, and frontal sinuses. The soft tissue density lesions signify inflammatory polyposis and retained secretions, though significant aeration is visible compared to total opacification. The nasal septum is midline, and the turbinate structures are clearly delineated. These images demonstrate the clinical and radiological presentation of eosinophilic chronic rhinosinusitis (ECRS) and are used to assess the Total Polyp Score (TPS) and Lund-Mackay Score (LMS) in response to treatment, such as biologics like dupilumab.
This composite figure illustrates the clinical and radiological response to treatment for eosinophilic chronic rhinosinusitis (ECRS) in an adult patient. Panel A displays a right-sided nasal endoscopy view showing a persistent, smooth, pale yellow-colored polypoid mass located within the olfactory fissure (marked by a white arrow). Panel B presents a left-sided nasal endoscopy view showing resolution of previously documented nasal polyps, with visible nasal mucosa and patent passages. Panel C is a coronal paranasal sinus CT scan following four months of therapy, demonstrating significant improvement in sinus aeration. The black, air-filled spaces within the maxillary, ethmoid, and frontal sinuses indicate reduced mucosal thickening and clearance of soft-tissue opacities, although residual mucosal thickening remains visible in the floor of the maxillary sinuses. Collectively, the images provide a comparison of endoscopically visible localized disease versus global sinus improvement monitored via diagnostic imaging.
A multi-modal comparison of Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) and with Nasal Polyps (CRSwNP). The image is divided into two clinical panels, each containing endoscopy, CT imaging, and histopathology. The CRSsNP panel (left) shows endoscopic nasal mucosal thickening, a coronal CT scan with ethmoid sinus opacification, and a light microscopy image (H&E, x100) labeled 'FIBROSIS'. This state is characterized by high levels of IFN̳, TGF̲1, and Activin A, and a low Follistatin/activin A ratio. The CRSwNP panel (right) displays endoscopic visualization of translucent nasal polyps, a coronal CT scan showing extensive sinus opacification, and a histopathological image (EG2, x100) labeled 'EDEMA'. It highlights eosinophilic infiltration (red staining) with high levels of IL-5 and ECP, but low TGF̲1 and Activin A. This comparison illustrates the different tissue remodeling patterns in CRS: predominant fibrosis and Th1/pro-fibrotic markers in CRSsNP versus predominant edema and Th2 markers in CRSwNP.
Educational visual panel depicting a rabbit model of chronic rhinosinusitis (CRS) at 14 weeks. (A) Coronal micro-CT scan of the paranasal sinuses demonstrating partial opacification of the left maxillary and ethmoid sinuses (yellow asterisks), indicating fluid or mucosal thickening. (B) Nasal endoscopy image showing the left middle meatus with purulent secretions (yellow arrow) positioned between the middle turbinate and the lateral nasal wall. (C) H&E stained histopathology slide showing significant infiltration of chronic inflammatory cells (plasma cells and lymphocytes), epithelial hyperplasia, and submucosal edema. (D) Periodic Acid-Schiff (PAS) stained comparison between control (upper) and chronic sinusitis (lower) tissue. The chronic group exhibits marked hypertrophy and increased density of submucous glands, staining deep purple, which characterizes mucus hyperplasia. This composite illustrates diagnostic imaging, clinical findings, and microscopic cellular changes associated with long-term sinus inflammation.
Chronic Rhinosinusitis (CRS) - ENT (MBBS)
Definition
"CRS is diagnosed when symptoms last more than 12 consecutive weeks." - Cummings Otolaryngology
Classification (High-Yield)
| Feature | CRS without Nasal Polyps (CRSsNP) | CRS with Nasal Polyps (CRSwNP) |
|---|---|---|
| Sex predominance | More common in women | More common in men |
| Age of onset | Childhood / young adulthood | Adulthood |
| Inflammation type | TH1-mediated, IFN-γ dominant | TH2-mediated, eosinophilic |
| Histology | Fibrosis, BM thickening, goblet cell hyperplasia, mononuclear infiltrate | Edematous stroma, albumin deposition, pseudocyst formation, eosinophilic infiltrate |
| Key cytokines | IFN-γ high; TGF-β1 high | IL-5 high; ECP (eosinophil cationic protein) high |
| Presenting symptom | Facial pain/pressure dominant | Decreased/loss of smell dominant |
| Associations | Bacterial infection/colonization, deviated septum | Asthma, aspirin sensitivity (Samter triad), AFRS |
Subtypes of CRS:
- CRSsNP - without polyps
- CRSwNP - with nasal polyps (most common polypoidal form)
- Allergic Fungal Rhinosinusitis (AFRS) - associated with polyps; IgE-mediated; characteristic "peanut butter" greenish-brown mucus
- Pediatric CRS
Pathophysiology
OMC Obstruction
↓
Impaired mucociliary clearance + Reduced ventilation
↓
Mucus stasis + Bacterial colonization
↓
Persistent mucosal inflammation
↓
Chronic Rhinosinusitis
- Bacterial superantigen response (Staphylococcal enterotoxins)
- Fungal sensitization
- Atopy and allergens
- Biofilm formation (polymicrobial - S. aureus, P. aeruginosa)
- Osteitis (bone remodeling)
- Unified airway disease (association with lower airway disease)
CRSsNP: TH1 milieu with increased IFN-γ in inflamed mucosa and fibrotic remodeling
Endoscopy and CT Imaging Comparison: CRSsNP vs CRSwNP
Clinical Features
Cardinal Symptoms (EPOS Diagnostic Criteria)
- Nasal obstruction / congestion (blockage)
- Nasal discharge - anterior rhinorrhea or postnasal drip (may be mucopurulent)
- Facial pain / pressure / fullness
- Reduction or loss of smell (hyposmia/anosmia) - more prominent in CRSwNP
"Cardinal symptoms: facial pain or pressure, nasal discharge or postnasal drip, congestion, and hyposmia or anosmia." - Harrison's Principles 22E
Additional/Associated Symptoms:
- Fatigue and malaise
- Ear pressure / fullness
- Hoarseness (from postnasal drip)
- Chronic cough
- Headache
- Sleep disturbance
Sinus-Specific Pain Locations:
| Sinus | Pain Location |
|---|---|
| Maxillary | Cheek, upper teeth, infraorbital region |
| Frontal | Forehead, supraorbital area |
| Ethmoid | Between eyes, medial canthal region, bridge of nose |
| Sphenoid | Vertex of skull, occiput, retro-orbital ("worst headache") |
Signs on Examination:
- Mucosal erythema and edema
- Mucopurulent discharge in the middle meatus
- Nasal polyps: pale/grey/yellow translucent growths in middle meatus (in CRSwNP)
- Nasal septal deviation (predisposing factor)
- Mucosal disease in middle meatus and ethmoid bulla
- Purulent secretions from sinus ostia
- Polyps visualized
- Posterior disease (sphenoid/posterior ethmoid) not visible on anterior rhinoscopy
Nasal Polyps: Key Features
- Appear as white, grey, tan, or yellow translucent growths
- Arise from the middle meatus (bilateral and multiple in CRSwNP)
- Pale and insensate (do not bleed on probing - differentiates from turbinate hypertrophy)
- Unilateral polyp = always suspect malignancy (inverted papilloma, SCC, especially in older patients / wood-dust exposure)
- Nasal polyposis + Bronchial asthma + Aspirin/NSAID sensitivity
Investigations
1. Nasal Endoscopy
- Best for confirming mucosal inflammation in middle meatus and posterior areas invisible on anterior rhinoscopy
- Visualizes polyps, purulent secretions, anatomical variants
2. CT Paranasal Sinuses (Non-contrast) - Imaging of Choice
- Coronal cuts are most informative (shows OMC anatomy clearly)
- Findings in CRS:
- Diffuse or polypoid mucosal thickening
- Partial or complete opacification of sinuses
- Bone remodeling/thickening (osteitis)
- Intrasinus calcifications
- OMU obstruction (infundibular, OMC, or sphenoethmoidal recess patterns)
- Chronic secretions: increased density (30-60 HU) vs acute (10-25 HU)
-
40% of patients with symptom-based CRS have normal CT - objective confirmation is mandatory
- Each sinus scored 0 (clear), 1 (partial opacification), 2 (complete opacification)
- OMC scored 0 or 2
- Maximum total score: 24
3. Nasal Swab / Culture
- To identify organisms and antibiotic sensitivity
- Important in recurrent/recalcitrant cases
4. Allergy Testing
- Skin prick test or RAST - important especially in CRSwNP
5. MRI
- Not routine; used when malignancy, fungal disease, or intracranial extension suspected
- Superior to CT for soft tissue differentiation
6. Special Tests (when indicated):
- Saccharin test / Ciliary biopsy - if primary ciliary dyskinesia suspected
- Sweat chloride test / CFTR mutation - if cystic fibrosis suspected
- Immunoglobulin levels - if immunodeficiency suspected
- ANCA, ACE levels - if granulomatous disease (Wegener's, sarcoid) suspected
Management
Step 1 - General/First-Line Medical Management
A. Saline Nasal Irrigation
- High-volume saline washes (e.g., Neil Med, Neti pot) - more effective than simple sprays
- Clears mucus, promotes drainage, reduces mucosal edema
- Safe, well-tolerated, used in all subtypes
B. Intranasal Corticosteroids (INCS) - Mainstay of Treatment
- Mometasone, Fluticasone, Budesonide (sprays or rinses)
- Reduce mucosal edema and polyp size
- High-volume budesonide rinses have superior evidence vs standard sprays for CRSwNP
- Should be tried for at least 4 weeks by primary care before ENT referral (EPOS guidelines)
- Excellent safety profile; minimal systemic absorption
C. Antibiotics
- Role is limited in CRS; not first-line
- Macrolides (e.g., clarithromycin, azithromycin) for 3 months - modest quality evidence supports use in CRSsNP without polyps (anti-inflammatory + antibacterial mechanism)
- Short-course antibiotics (2-4 weeks) frequently prescribed but little evidence of benefit
- Biofilm-forming organisms (S. aureus, P. aeruginosa) lead to resistance
- Antifungal agents: NOT recommended for any subtype of CRS
D. Oral Corticosteroids
- Short course (2-3 weeks) for CRS unresponsive to intranasal steroids
- Especially effective for CRSwNP (shrinks polyps temporarily)
- Used as "rescue" or bridging therapy
E. Antihistamines
- For patients with allergic component (IgE-mediated disease)
- Intranasal or systemic
F. Leukotriene Antagonists
- Montelukast - particularly helpful when allergic component present
- Useful adjunct in AERD/aspirin sensitivity
G. Decongestants
- Used sparingly and briefly only (risk of rhinitis medicamentosa with prolonged use)
Step 2 - Second-Line / Escalated Medical Management
Biologic Therapies (for Severe, Recalcitrant CRSwNP)
| Biologic | Mechanism | Target |
|---|---|---|
| Dupilumab (FDA approved) | Anti-IL-4Rα (blocks IL-4 + IL-13) | Type 2 inflammation |
| Mepolizumab | Anti-IL-5 | Eosinophil reduction |
| Benralizumab | Anti-IL-5Rα | Eosinophil depletion |
| Omalizumab | Anti-IgE | Allergic pathway |
- Meta-analysis (PMID: 39729039) confirms budesonide nasal irrigation benefits for CRS
- Biologics reduce polyp size and symptom burden, improving QOL
Step 3 - Surgical Management
Indications for Surgery:
- Failure of appropriate maximal medical therapy (most common indication)
- CT-confirmed residual disease after medical treatment
- Complications of CRS
- Suspected malignancy
- Antrochoanal polyp (relative indication)
"CRS that is recalcitrant to medical therapy is the most common indication for surgery." - Cummings Otolaryngology
Functional Endoscopic Sinus Surgery (FESS) - Surgery of Choice
- Mucosal preservation (Messerklinger technique)
- Restoration of ventilation and drainage
- Removal of obstructing disease while preserving normal structures
- Provides wide passages for topical drug delivery post-operatively
- Relieve obstruction at OMC
- Restore mucociliary clearance
- May be curative in some subtypes (e.g., odontogenic sinusitis)
- Remove polyps and debris
- Complete ethmoidectomy (most critical step)
- Create wide sinus openings for topical medication delivery
- Surgery adjunctive - long-term medical therapy still required post-FESS
- Uncinectomy (removal of uncinate process)
- Middle meatal antrostomy (maxillary sinus opening)
- Anterior ethmoidectomy
- Posterior ethmoidectomy
- Sphenoidotomy
- Frontal sinusotomy (Draf procedures for frontal sinus)
Other Surgical Options:
- Polypectomy - simple removal; often combined with FESS
- Caldwell-Luc operation - now largely obsolete; reserved for specific indications
- Adenoidectomy - effective in pediatric CRS
Pre-surgical Requirements (Scott-Brown's):
- CT scan must be obtained to:
- Assess residual disease
- Identify anatomical risk factors
- Plan surgical approach
- Informed consent including:
- Natural history of disease
- Surgical complications (orbital, intracranial injury)
- Risk of recurrence
- Need for ongoing medical management
Special Associations (High-Yield)
Samter's Triad (AERD):
- Nasal polyposis + Asthma + Aspirin/NSAID sensitivity
- Treatment: salicylate desensitization therapy
Allergic Fungal Rhinosinusitis (AFRS):
- Occurs in 20s-30s; warm, humid regions; atopic patients
- Characteristic mucus: thick, greenish-brown, peanut butter consistency with fungal hyphae (Aspergillus)
- CT: double-density sign, often unilateral, can expand sinus walls
- Resistant to medical therapy; surgery + perioperative steroids is treatment of choice
Cystic Fibrosis:
- Nearly universal CRS and nasal polyps
- Young patients with bilateral polyps should be tested
Primary Ciliary Dyskinesia (Kartagener's syndrome):
- CRS + bronchiectasis + situs inversus
- Defective cilia - impaired mucociliary clearance
Granulomatous Disease:
- Granulomatosis with polyangiitis (Wegener's): ANCA positive; saddle nose deformity
- Sarcoidosis: lupus pernio, non-caseating granulomas
Complications of CRS
| Category | Complications |
|---|---|
| Orbital (most common) | Periorbital edema, orbital cellulitis, subperiosteal abscess, orbital abscess, cavernous sinus thrombosis |
| Intracranial | Meningitis, epidural abscess, subdural empyema, brain abscess |
| Osseous | Osteomyelitis, Pott's puffy tumour (frontal bone osteomyelitis) |
| Local | Mucocele, mucopyocele |
Key High-Yield Summary Table
| Feature | Detail |
|---|---|
| Definition | >12 weeks of rhinosinusitis symptoms |
| Cardinal symptoms | Obstruction, discharge, facial pain/pressure, hyposmia/anosmia (≥2 needed) |
| Imaging of choice | Non-contrast CT PNS (coronal cuts) |
| Best for diagnosis | Nasal endoscopy + CT (combined) |
| CRSsNP inflammation | TH1, IFN-γ, fibrosis |
| CRSwNP inflammation | TH2, IL-5, ECP, eosinophilic edema |
| Polyp appearance | Pale, grey, translucent; insensate; bilateral (middle meatus) |
| Unilateral polyp | Suspect malignancy / inverted papilloma |
| Mainstay medical Rx | Intranasal corticosteroids + saline irrigation |
| Antibiotics | Macrolides 3 months for CRSsNP; limited evidence overall |
| Antifungals | NOT indicated in standard CRS |
| Surgery | FESS (after failed medical therapy) |
| Samter's Triad | Polyps + Asthma + Aspirin sensitivity |
| AFRS mucus | Thick, peanut butter, greenish-brown |
| Pediatric CRS surgery | Adenoidectomy first-line |
| CT scoring | Lund-Mackay system |
| Biologic for refractory CRSwNP | Dupilumab (anti-IL-4Rα) |
Sources
- Cummings Otolaryngology Head and Neck Surgery - Chapters 38, 43, 44
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery Vol.1 - Chapter 94
- Harrison's Principles of Internal Medicine 22E (2025) - Chronic Sinusitis
- K.J. Lee's Essential Otolaryngology
- Goldman-Cecil Medicine International Edition
- Payne SC et al. Executive Summary - Clinical Practice Guideline on Adult Sinusitis Update. Otolaryngol Head Neck Surg. Aug 2025
- Shin JJ et al. Clinical Practice Guideline: Surgical Management of CRS. Otolaryngol Head Neck Surg. Jun 2025
- Magboul N et al. Budesonide nasal irrigation for CRS: meta-analysis. Rhinology. 2025